Healthcare News – Read More An experimental personalized mRNA-based cancer vaccine from Merck and Moderna was successful at preventing melanoma from returning or spreading in a late-stage trial of high risk patients, the companies announced Wednesday. The positive results mean a potentially life-extending treatment is one step closer to being available on the market. They also herald a significant and…
Moderna, Merck mRNA cancer vaccine prevents melanoma from returning
HootMD curates medical news from trusted publishers. Follow the links in this article to read the full story at the original source.
